In the CD cohort, pathways related to IBD, the intestinal immune network for IgA production, and asthma were activated, whereas those related to the metabolism of xenobiotics by cytochrome P450, metabolism of drugs by cytochrome P450, and butanoate metabolism were inhibited (Fig. 5E,H). This evidence concerns the gene CD79A and inflammatory bowel disease.